The FDA has granted Breakthrough Therapy designation to BPL-003 (mebufotenin benzoate) nasal spray for adults with treatment-resistant depression.

Longitudinal data shows increasing or high addictive use of social media and mobile phones in adolescents significantly raises the risk of suicidal behaviors and ideation.

Uzedy administered once every 2 months is not recommended for the maintenance treatment of bipolar I disorder. The Food and Drug Administration (FDA) has approved Uzedy ® (risperidone extended-release ...

Exercise snacks were defined as structured bouts lasting five minutes or more, performed at least twice daily, three times or more per week, for two weeks or more. (HealthDay News) — Brief bouts of ...

The researchers found that during a median 5.72 years of follow-up, 150 incident ALS cases were recorded, yielding 7.05 cases per 100,000 person-years. (HealthDay News) — The risk for amyotrophic ...

Resilience training (RT), a brief mindfulness-based intervention, reduced early psychopathology, emotion reactivity, and altered hippocampal-prefrontal brain connectivity in at-risk young adults.

After 30 days with ambient AI scribe, proportion of participants experiencing burnout decreased from 51.9 to 38.8 percent ...

This 3-part series looks at the evidence for the treatment of SUDs reviews & the use of GLP-1 receptor agonists and alcohol use disorder.

(HealthDay News) — The suicide count in a county increases as pollen levels rise, according to a study published in the December issue of the Journal of Health Economics. Joelle Abramowitz, Ph.D., ...